NCT05803954

Brief Summary

This study will be conducted to compare the effect of sustained natural apophyseal glides (SNAGS) versus neural mobilization on clinical outcomes such as 1- nerve root function in the form of: (A) peak to peak amplitude; (B) latency; (C) F wave. 2- pain pressure threshold (PPT) and 3- Neck disability index (NDI) in patients with cervical disc (C5-C6 and/or C6-C7) herniation. Seventy two patients from both gender with cervical disc (C 5-C 6 and/or C 6- C7) herniation with both sensory and motor nerve affections will be recruited for this study following referral from an experienced neurologist and confirmed diagnosis by MRI. The patients' age will range between 20-50 years, body mass index (BMI) from 18 to 25 kg/cm2. The patients will be assigned randomly by permuted block to three equal groups; group (A) will receive SNAGS in addition to traditional therapy, group (B) will receive neural mobilization in addition to traditional therapy and group (C) will receive traditional therapy. peak to peak amplitude, nerve latency and F wave will be measured by electromyography, , pressure pain threshold will be measured by commander algometer. Neck disability will be measured by Arabic neck disability index.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

March 31, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 7, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

July 6, 2023

Status Verified

July 1, 2023

Enrollment Period

3 months

First QC Date

March 25, 2023

Last Update Submit

July 5, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • F-wave parameters

    Evaluation of the spinal motoneuron excitability through the measurement of the F wave parameters

    Change over the course of the study, from baseline to the end of treatment program at 4 weeks

  • Somatosensory Evoked Potentials (SEPs) Latency and Amplitude

    SEPs are the electrical signals generated by the nervous system in response to somatosensory stimuli. SEPs are read on the skull with electroencephalography (EEG)

    Change over the course of the study, from baseline to the end of treatment program at 4 weeks

  • Pain pressure threshold by Pressure algometer

    An algometer will be used used to quantify pain intensity by pressure

    Change over the course of the study, from baseline to the end of treatment program at 4 weeks

Secondary Outcomes (1)

  • Neck disability Index

    Change over the course of the study, from baseline to the end of treatment program at 4 weeks

Study Arms (3)

Group A (SNAGs group)

EXPERIMENTAL
Other: Sustained natural apophyseal glides (SNAGS)Other: Traditional physical therapy

Group B (Neural mobilization group)

EXPERIMENTAL
Other: Neural mobilizationOther: Traditional physical therapy

Group C (traditional physical therapy)

ACTIVE COMPARATOR
Other: Traditional physical therapy

Interventions

SNAGS will be applied with the patient sitting comfortably on a stool. The therapist stand behind the patient and the medial border of one thumb's distal phalanx is placed on the articular pillar on the chosen side of the suspected site of lesion. The thumb nail slope at approximately 45 degree (in the direction of the eyeball). SNAGS mulligan will be given by active movement followed by passive overpressure based on the movement restricted by frequency of treatment will be three sets of ten repetitions. SNAG the anteroposterior mobilization of the second cervical vertebrae is sustained for 10 to 30 s depending on response. A maximum of 6 repetitions will be given if there is a reduction in headache intensity at the time of the first application. A total of 20 oscillations (1 oscillation/1 second) will be given to each joint with a total duration of 15 minutes

Group A (SNAGs group)

Neural mobilization will be applied with grade three neural mobilization and traditional therapy: Subjects will be placed in supine position and remained relaxed with the feet uncrossed. The patient will be slightly angled obliquely for easier access to the scapula. The therapist will be depressed the scapula with concomitant upper extremity joint positioning as per median nerve bias i.e., ULTT2 (shoulder abduction, elbow extension with forearm supination, wrist and fingers extended and ulnar deviated and thumb abduction). The wrist will be used as a tension factor and at the point where tension was felt by the therapist and perceived by the subject. Grade 3 oscillations were given rhythmically and slowly to each joint from proximal to distal. A total of 20 oscillations (1 oscillation/1 second) were given to each joint with a total duration of 15 minutes.

Group B (Neural mobilization group)

traditional therapy will be applied in the form of stretching for bilateral upper and middle trapezius muscles and bilateral neck rotators and isometric strengthening exercises for neck rotators, extensors, side bending muscles. Exercise was repeated for ten repetitions per session. In addition to hot pack was placed over the neck and upper part of shoulders musculature. This was being applied for ten min, over middle trapezius trigger Point itself.

Group A (SNAGs group)Group B (Neural mobilization group)Group C (traditional physical therapy)

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • seventy patients with cervical disc (C 5-C 6 and/or C 6- C7) herniation with both sensory and motor nerve affections, referred from neurologist and confirmed diagnosis by MRI
  • Both sexes.
  • Age between 20-50 years.
  • Patients with neck pain radiating down to the arm.
  • Patients with positive findings for spurling test, Upper Limb Tension Test One (ULTTO), cervical distraction test and cervical rotation test towards the symptomatic side \<60.
  • BMI from 18 to 25 kg/cm2
  • Existed active trigger points within middle trapezius and/ or cervical region.
  • Positive Pittsburgh sleep quality index' value \>10, means moderate and/ or sever difficulty.

You may not qualify if:

  • Patients experiencing primary shoulder or upper extremity problem of local origin
  • cardiovascular disorders and respiratory disorders,
  • pathological conditions involving cervical spine like vertebro basilar insufficiency and canal stenosis
  • osteophytes in cervical vertebrae
  • Patients who were undergoing treatment for neck pain with other means of physiotherapy at the time of the study
  • Cervical fractures, spinal surgery or other spinal pathologies (i.e. ankylosing spondylitis, spondylolisthesis)
  • Peripheral nerve lesions like neurotmesis and axonotmesis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ismailia medical complex

Ismailia, Egypt

Location

MeSH Terms

Conditions

Intervertebral Disc DisplacementRadiculopathy

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Amany I. Selem, BSc

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 25, 2023

First Posted

April 7, 2023

Study Start

March 31, 2023

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

July 6, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations